Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2021

View Archived Issues

New phase II/III study evaluates BLU-263 in patients with indolent systemic mastocytosis

Mechanism identified for HBsAg reduction with Aligos Therapeutics STOPS molecule ALG-10000

Newly identified lncRNA could be a biomarker of liver and pancreatic cancers

Morehouse School of Medicine Chlamydia vaccine VCG-Pmp18.3 is protective in vivo

Positive phase I data for AKS-452, a protein subunit COVID-19 vaccine candidate

Crinetics Pharmaceuticals synthesizes melanocortin MC2 receptor antagonists

Landos Biopharma patents new LANCL2 activators

U.S. Department of Health & Human Services divulges compounds for HIV infection

Janssen Pharmaceutica discloses new OGA inhibitors

Genentech patents anti-LY6G6D antibodies for colorectal cancer

Evaxion presents phase I/IIa data for its cancer immunotherapy candidates, EVX-01 and EVX-02

Study casts further light on cancer immunotherapy

Discovery, optimization and in vivo evaluation of novel tetrahydropyran-based galectin-3 inhibitors

Results of two trials of chemoattenuated PfSPZ vaccines in controlled human malaria infections

EDP-721, a novel HBV RNA destabilizer with promising preclinical efficacy

HDAC6 inhibitors improve LVEF in murine model of DCM

YH-34160 leads to potent and sustained body weight loss in DIO mouse model

Bioasis reports outcome of preclinical study of xB3-IL-1RA for MS

FDA clears eIND for 68Ga-RMX-VH in glioblastoma multiforme

Biomarker panel identifies cardiovascular risk and benefit from SGLT2 inhibitors

Novel SARS-CoV-2 inactivated vaccine induces robust immune responses in healthy adults

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...